Skip to main content
. 2019 Sep 16;12(3):137. doi: 10.3390/ph12030137
AGP asiaglycoprotein
AGPR asiaglycoprotein receptor
t-butyl-HBED N,N′-Bis(5-t-butyl-2-hydroxy3-methylbenzyl)ethylenediamine-N,N′-diacetic acid
BOPTA benzyloxymethyl-DTPA
BRIDA 3-bromo-2,4,6-trimethyl-IDA (mebrofenin)
BP-IDA tetra-bromo-ortho-cresolphthalein IDA
CA contrast agent
Cy2DOT hexadecahydro-dibenzo[b,h][1,4,7,10]tetraazacyclododecine5,8,13,16-tetraacetic acid
DAZA 1,4-diazepane-6-amine
3,4-DiP-LICAM N,N′-bis(iso-propyl)-N,N′,N″-tris(2,3-dihydroxybenzoyl)-l,5,10-triazadecane
DISIDA 2,6-diisopropyl-IDA
2,5-BPA-DO3A 10-[2-[(2,5-bis(isopropyl)phenyl)amino]-2-oxoethyl]-DO3A
DO3A 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
DOTA 1,4,7-10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
DTPA diethylenetriamine pentaacetic acid
DPDP dipyridoxyl-ethylendiamindiacetate-diphosphate
EDTA ethylenediamine tetraacetic acid
EHIDA 2,6-diethyl-IDA
EMA European Medicines Agency
EOB p-ethoxybenzyl
GSA galactosyl serum albumin
HCC hepatocellular carcinoma
HIDA 2,6-dimethyl-IDA
IOTIDA 3-iodo-2,4,6-trimethyl-IDA
ID injected dose
IDA phenylcarbamoylmethyl iminidoacetic acid
i.v. intravenous
MRI magnetic resonance imaging
MRP multidrug resistance protein
NAFDL non-alcoholic fatty liver disease
NGA galactosyl-neoglycoalbumin
NOTA 1,4,7-triazacyclononane-1,4,7-triacetic acid
NSF nephrogenic systemic fibrosis
NTCP Na+/taurocholate co-transporting polypeptide
OATP organic anion transporter
PET positron emission tomography
p.i. post injection
PMT N-pyridoxyl-5-methyltryptophane
PIPIDA p-isopropyl-IDA
PyC3A N-picolyl-N,N′,N′-trans-1,2-cyclohexylenediaminetriacetate
PyC3A-3-OBn N-[(3-benzyloxy)picolyl]-N,N′,N′-trans-1,2-cyclohexylenediaminetriacetate
RNS reactive nitrogen species
ROS reactive oxygen species
RES reticuloendothelial system
SOD superoxide dismutase
SPECT single photon emission tomography
SPIO superparamagnetic iron oxide
TEtOHB-DAZA N,1,4-Tri(4-ethoxy-2-hydroxybenzyl)-DAZA
USPIO Ultra-small superparamagnetic iron oxide